CAS: 1295298-26-8
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | CCR1 antagonist 8 REF: 3D-VBC29826CAS: 1295298-26-8 | Min. 95% | To inquire | Wed 26 Jun 24 |
 | CCR1 antagonist 8 REF: TM-T14899CAS: 1295298-26-8 | - - - | To inquire | Wed 14 Aug 24 |
CCR1 antagonist 8
CAS:1295298-26-8
CAS No. 1295298-26-8 is a peptide that belongs to the class of activators with an …
Formula:
C22H18FN5O3S
Purity:
Min. 95%
Molecular weight:
451.5 g/mol
Ref: 3D-VBC29826
| 1mg | To inquire | |
| 5mg | To inquire | |
| 10mg | To inquire | |
| 25mg | To inquire | |
| 50mg | To inquire |
Estimated delivery in United States, on Wednesday 26 Jun 2024
CCR1 antagonist 8
CAS:1295298-26-8
CCR1 antagonist 8, a third azaindazole series compound, is a CCR1 antagonist (IC50: 1.8 nM …
Formula:
C22H18FN5O3S
Molecular weight:
451.47
Ref: TM-T14899
| 25mg | 1,002.00 € | |
| 50mg | 1,320.00 € | |
| 100mg | 1,994.00 € |
Estimated delivery in United States, on Wednesday 14 Aug 2024
